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IT was reported by Woodruff and Symes (1962a, b) that the growth of spon-
taneous A-strain mouse mammary carcinomata, or early transplant generations
thereof to isogenic hosts, was associated with hyperplasia ofthe spleen and lymph
nodes, which, microscopically, was characteristic of immunological stimulation.
It was suggested that this stimulation occurred in response to specific antigens
possessed by the tumour. The finding that, following repeated transplantation
within the strain of origin, the tumour no longer produced evidence of immuno-
logical stimulation in the host, led to the hypothesis that one ofthe characteristics
of progressive malignant growth was the deletion of tumour specific antigens.
The purpose of the present communications is, first, to study the mechanism
by which antigen deletion may occur, and second to correlate its occurrence with
other evidence of increasing malignancy on the part of the tumour.
Theoretically deletion oftumour specific antigens could occur as a fundamental
property of the malignant cells themselves, or as part of an adaptive response by
the cells to immunological attack mounted against them by the host. An attempt
has been made to distinguish between these possibilities by comparing the rates
of antigen deletion shown by the same tumour maintained separately as two
lines; one inuntreated isogenic hosts andthe otherin similar hosts whose immuno-
logical function had been depressed by prior administration of L-phenylalanine
mustard (Melphalan).
MATERIALS AND METHODS
Mice and'tumours studied
Highly inbred A-strain mice of both sexes maintained in this department by
strict brother x sister mating have been used throughout the investigation.
Two mammary carcinomata arising spontaneously in female A-strain mice
were studied. The first tumour " A " (kindly supplied by Professor M. F. A.
Woodruff) was obtained as a first generation transplant in an isogenic host, the
second tumour " B " arose spontaneously in a member of the A-strain colony of
this department.
Mode of tumour transplantation
The method of tumour transplantation was that described by Woodruff and
Symes (1962a) and the scheme employed is shown in Fig. 1. The " normal line "
oftumour was maintained by serial transplantation ofthe spontaneously occurringM. 0. SYMES
tumour into groups of six untreated mice at intervals of two weeks. The " Mel-
phalan line " of tumour was composed of groups of three untreated mice, each of
which received a transplant, from tumour " A " or " B ", which had grown for
the proceeding two weeks in a mouse treated with Melphalan twenty-four hours
before tumour transplantation. At the same time as the tumour growing in a
Melphalan pre-treated mouse was transplanted into untreated mice to form a
passage of the "Melphalan line ", a further transplant from this tumour was
made to another Melphalan pre-treated mouse. This latter animal, two weeks
later, served as the tumour donor for a further three untreated mice, which thus
comprised the next passage of the " Melphalan line ".
PASSAGE A (SPONTANEOUS TUMOUR)
NUMBER
1St A A (2 weeks)
2nd A A A (2weeks) A A A
3 rd A A A (2weeks) A A A
NORMAL LINE etc. MELPHALAN LINE
FIG. 1.-Scheme of tumour transplantation.
A = untreated mouse.
r)A= Mouse receiving 15 mg./kg. body weight Melphalan subcutaneously 24 hours before
tumour transplantation.
Observations on animals bearing tumour transplants
At each succeeding passage of the tumour, in both the " normal " and " Mel-
phalan " lines, the diameter ofthe tumour, at fourteen days after transplantation,
was measured to the nearest millimeter using a caliper. The three mice in the
" Melphalan line " together with three of the mice from the " normal line"
were then killed by cervical dislocation and weighed to the nearest 0-5 g.
The spleen, thymus and lymph nodes (two axillary + one inguinal) on the
side of the mouse bearing the tumour (designated ipsilateral) and on the opposite
side (designated contralateral) were removed and weighed to the nearest 0.1 mg.
The relative spleen weight was calculated using the expression
Wt. of spleen (mg.)
Wt. of mouse (g.)
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FIG. 2.-Mean tumour diameters on Day 14 at each passage of the tumour from the "normal"
and " Melphalan " lines.
Administration of Melphalan
Melphalan was dissolved in 96 % ethyl alcohol containing 4*8 % v/v hydro-
chloric acid and the resulting solution was subsequently adjusted to approximately
pH 7 by the addition of 1-2 % w/v di-potassium hydrogen phosphate in aqueous
propylene glycol. A dose of 15 mg./kg. mouse body weight was injected subcu-
taneously on the opposite side of the body to the subsequent tumour transplant.
RESULTS
The results for tumour " A " are presented in detail in Table I and summarised
in Fig. 2 and 4. The results for tumour " B " are likewise shown in Table II and
Fig. 2 and 5.M. 0. SYMES
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Results obtained from the mouse in which each tumour arose spontaneously
are included, but are not, ofcourse, comparable with those obtained for subsequent
passages of the tumour, as the time for which the spontaneous tumour had been
present was considerably more than fourteen days.
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FIG. 4.-Lymph node and relative spleen weights at successive passages of tumour " A ".
In the case of both tumours " A " and " B ", tumour from the " Melphalan
line " grew more slowly than the tumour from the corresponding passage of the
" normal line " (Fig. 3). However the tumour growth rate for the sixth passage
in the " Melphalan line " of tumour " A " showed a marked increase compared
with that in previous passages of this line.
In the case of " normal "lines from both tumours, the weights ofthe ipsilateral
and contralateral lymphnodesfrom the host were markedlyraisedin earlypassagesz ~I
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FiG. 5.-Lymph node and relative spleen weights at successive passages of tumour B
of the tumour, but became normal* as the number of passages increased, thus
confirming the previous observation of Woodruff and Symes (1962b).
The lymph node weights of mice bearing early transplant generations of the
"Melphalan" tumour line were also raised and remained so in later passages,
when the lymph node weights of mice bearing the corresponding passage of the
"cnormal line " of the tumour were not increased.
* Data for the relative spleen and lymph node weights from ten normal adult A-strain female mice
were as follows: (Woodruff and Symes 1962b).
Relative spleen weight 6 10 ± 0-94.
Weight of lymph nodes on the right side (corresponding to ipsilateral) 23 9 ±1 492 mg.
Weight oflymph nodes on the left side (corresponding to contralateral) 22 7 ± 458 mg.
The corresponding values for male mice are similar.
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The relative spleen weights ofmice bearing the " normal " lines ofboth tumours
also showed evidence ofincrease which for a time was progressive as the number of
tumour passages increased. However, as the tumour was passaged still further
the relative spleen weights ofthe hosts, either declined in the case oftumour " A"
or even returned to normal, as in the case of tumour " B ".
It may also be noted that at a time when the relative spleen weights of the
mice bearing the " normal " tumour lines were increasing the corresponding
lymph node weights were decreasing.
With the " Melphalan " lines of both tumours increase in the host relative
spleen weight was much less marked than for the corresponding passages in the
" normal line ". Indeed in the case of tumour " A " increase in the spleen weight
was possibly commencing at the sixth passage in the "Melphalan line ", whilst
in the case oftumour " B " no such increase was seen in the transplant generations
studied.
The degree ofspleen and lymph node response was greater in the case oftumour
"A " than of tumour "B ".
There was no significant difference between the thymic weights ofmice bearing
corresponding passages from the " normal " or "Melphalan " lines of tumours
" A "or " B ". Furthermore there was no significant change inthe thymicweights
of mice bearing successive passages of the same line from the same tumour, the
weights remaining similar to those for untreated mice throughout.
DISCUSSION
The results presented above show that as a spontaneous tumour is passaged
serially in untreated isogenic hosts, a morphological response indicative ofimmuno-
logical stimulation occurs, first in the lymph nodes and then in the spleen, before
finally disappearing as the number of passages is further increased.
When the same experiment is carried out using a tumour maintained in hosts
whose faculty ofimmunological response has been depressed, the same sequence of
changes is seen, but it takes a greater number of passages to occur.
The relative sequence ofchanges in the spleen and lymph nodes ofhosts bearing
" normal " and " Melphalan " lines of the tumours are correlated with the slower
growth rate, in untreated hosts, of the "Melphalan " tumour line as compared
with the " normal " tumour line.
That the cycle of changes in the host spleen and lymph nodes, together with
the increase in tumour growth rate, occurs more slowly with the " Melphalan line "
of tumour, than with the " normal line ", suggests that the deletion of tumour
specific antigens is due to the host's immunological response to these antigens. It
is possible that such a host response selectively eliminates those tumour cells
possessing most specific antigenicity, leaving the remainder free to proliferate.
It seems reasonable to assume that the lymph nodes draining a subcutaneous
tumour transplant should respond to the presence of specific tumour antigens
before the spleen, which may, as Symes (1963) has suggested, function in the mouse
as a central immunological reserve.
It is unlikely that any direct effect was exerted by the Melphalan upon the
tumour, as in every case, the drug was administered twenty-four hours before
tumour transplantation and the " NlMelphalan line " of tumour " A ", which was
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studied through most passages, showed a higher growth rate at the sixth passage
than in the third.
Whereas Woodruff (1963, personal communication), has suggested that many
human tumours may be destroyed by the host's immune response to their specific
antigens before they are ever recognised clinically, the clinically detectable
neoplasm may depend, in part, for its further progress on the inducement offered
by the host's immune response to the deletion of its specific antigens. Thus
immunological depression arising in the host from attempts to treat tumours by
irradiation, administration of cytotoxic drugs, or foreign immunologically com-
petent cells, may not be so disadvantageous as has been feared.
SUMMARY
Two spontaneous A-strain mouse mammary carcinomata were each maintained
in two groups ofisogenic hosts by serial transplantation. The first group of mice
was untreated; the secondreceived 15 mg./kg. bodyweight ofL-phenylalanine mus-
tard (Melphalan) one day before tumour transplantation. At each passage a
portion of tumour from each group of hosts was transplanted to further normal
mice, the tumour growth rates and ability to produce evidence of immunological
stimulation being compared after fourteen days. Successive passages of the
tumour in the "Melphalan line " grew more slowly and this was correlated with
a more persistent immunological response by the host.
The implications ofthese findings are discussed.
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EXPLANATION OF PLATE
FIG. 3.-The six A-strain female mice shown had each received a transplant from the fourth
passage of tumour " A ", fourteen days beforehand. The three mice below comprise the
" Melphalan line " and those above the " normal line ". The difference in tumour size
between the two groups may be seen.Vol. XIX, No. 1. BJRITISH JOURNAL OF CANCER.
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